Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (191-200 of 317) with videos related to

Pageof 32
Sort By:
Anticancer Research|May 1, 1991
High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primaryI Gill, P Guaglianone, S M Grunberg, et al.
Medical and Pediatric Oncology|January 1, 1978
Visual abnormalities following nitrosourea treatmentA C Louie, A T Turrisi, F M Muggia, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
Effective adjuvant treatments. A brief review of U.S. clinical trialsA C Louie, M Rozencweig, D D von Hoff, et al.
Journal of Neuro-Oncology|June 1, 1990
Plasma carcinoembryonic antigen as an indicator of cerebral metastasesE A Eden, J M Muggia, E M Hiesiger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Calvert's formula and high-dose carboplatinB Uziely, S C Formenti, K Watkins, et al.
Cancer Treatment Reports|February 1, 1985
Mitomycin and methotrexate: negative experience in untreated colorectal carcinomaJ C Wernz, A K Kao, F M Muggia, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
m-AMSA and PALA: two new agents in cancer chemotherapyM Rozencweig, D D Von Hoff, R L Cysyk, et al.
Cancer Treatment Reports|June 1, 1979
Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activityR Catane, D D Von Hoff, D L Glaubiger, et al.
European Journal of Cancer|January 1, 1980
Surgical adjuvant trials in the United StatesM Rozencweig, D D Von Hoff, J C Allegra, et al.
Cancer Treatment Reports|November 1, 1979
The delta and epsilon errors in the assessment of cancer clinical trialsM J Staquet, M Rozencweig, D D Von Hoff, et al.
Pageof 32

Showing results (191-200 of 317) with videos related to

Sort By:
Pageof 32
Anticancer Research|May 1, 1991
High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primaryI Gill, P Guaglianone, S M Grunberg, et al.
Medical and Pediatric Oncology|January 1, 1978
Visual abnormalities following nitrosourea treatmentA C Louie, A T Turrisi, F M Muggia, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
Effective adjuvant treatments. A brief review of U.S. clinical trialsA C Louie, M Rozencweig, D D von Hoff, et al.
Journal of Neuro-Oncology|June 1, 1990
Plasma carcinoembryonic antigen as an indicator of cerebral metastasesE A Eden, J M Muggia, E M Hiesiger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Calvert's formula and high-dose carboplatinB Uziely, S C Formenti, K Watkins, et al.
Cancer Treatment Reports|February 1, 1985
Mitomycin and methotrexate: negative experience in untreated colorectal carcinomaJ C Wernz, A K Kao, F M Muggia, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
m-AMSA and PALA: two new agents in cancer chemotherapyM Rozencweig, D D Von Hoff, R L Cysyk, et al.
Cancer Treatment Reports|June 1, 1979
Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activityR Catane, D D Von Hoff, D L Glaubiger, et al.
European Journal of Cancer|January 1, 1980
Surgical adjuvant trials in the United StatesM Rozencweig, D D Von Hoff, J C Allegra, et al.
Cancer Treatment Reports|November 1, 1979
The delta and epsilon errors in the assessment of cancer clinical trialsM J Staquet, M Rozencweig, D D Von Hoff, et al.
Pageof 32